Spikevax (COVID-19 Vaccine, mRNA) 2024-2025 Formula - Moderna
WEBLearn about Moderna's Spikevax® (COVID-19 Vaccine, mRNA) 2024-2025 Formula and how it helps protect against emerging variants, following ACIP recommendation.
WEB1 SPIKEVAX is made the same way as the Moderna COVID-19 Vaccine (Original monovalent) and Moderna COVID-19 Vaccine, Bivalent, but it encodes the spike protein of SARS-CoV-2 Omicron variant...
WEBMost commonly reported adverse reactions following administration of SPIKEVAX or Moderna COVID-19 Vaccine, Bivalent containing the same amount of mRNA as the SPIKEVAX 2024-2025 Formula (≥10%):
Spikevax® (COVID-19 Vaccine, mRNA) - Moderna
WEBSPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) in individuals 12 years of age and older.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single)...
Moderna COVID-19 vaccine - Wikipedia
WEBThe Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Spikevax (previously COVID-19 Vaccine Moderna)
WEBJan 6, 2021 · Spikevax bivalent Original/Omicron BA.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against COVID-19.
Moderna COVID-19 vaccine (also known as Spikevax) overview …
WEBDetails: Alternative Title: Information about the Moderna COVID-19 Vaccine. Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Description: Updated June 24, 2022. Recommended for People 18 Years and Older and Children Ages 6 months to 5 Years. Primary Series:
Moderna COVID-19 Vaccine (2024-2025 Formula) | Moderna
WEBModerna COVID-19 Vaccine (2024-2025 Formula) has not been approved or licensed by the FDA, but has been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in …
SPIKEVAX® (COVID-19 Vaccine, mRNA) 2024-2025 Formula
WEBSPIKEVAX® (COVID-19 Vaccine, mRNA) 2024-2025 Formula PRESCRIBING INFORMATION PATIENT PACKAGE INSERT For more product information: Patients can visit SPIKEVAX.com Healthcare Professionals can visit SPIKEVAXPRO.com